SMAD4 and biliary tract neoplasm: Previous studies have revealed that common genomic alterations in biliary tract cancers, including TP53, KRAS, SMAD4, ARID1A, CDKN2A, IDH1, and PIK3CA mutations [3,15,16,19,20,21,36,37].